Evidence mapPaperPMID 9614255Full record

ArticleThe New England journal of medicine1998

Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study.

G S Berenson, S R Srinivasan, W Bao, W P Newman, R E Tracy, W A Wattigney

7 registry-linked trialsOpen access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in The New England journal of medicine, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 7 registered trials, which are not on this map. Cited by 1,098 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,098citing papers in PubMed, 5 pooled it
71.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01410604 phase4completedstarted 2007, after this paper: background citation

Inflammatory Mediators in Obese Adolescents With Insulin Resistance Following Metformin Treatment: Controlled Randomized Clinical Trial

Ran2007Enrolled31Registered outcomes8Posted comparisons0ConditionsObesityArmsMetformin, Placebo
Open the trial in the graph
NCT07590219 phase4active not recruitingstarted 2024, after this paper: background citation

Efficacy, Metabolic and Cardiovascular Effects of Liraglutide in Children Aged 6-12 Years With Severe Obesity: A Randomized Controlled Trial With Advanced Echocardiographic Assessment

Ran2024Enrolled30Registered outcomes9Posted comparisons0ConditionsCardiovascular Function, Childhood Obesity, Echocardiography, LiraglutideArmsLiraglutide (Saxenda) 6Mg/Ml Inj Pen 3Ml
Open the trial in the graph
NCT00005129 active not recruitingnot on this map

The Bogalusa Heart Study

TypeobservationalSponsorTulane UniversityRan1973 to 2029Enrolled11,737ConditionsAtherosclerosis, Cardiovascular Diseases, Heart Diseases, Coronary Disease
NCT01178515 phase4completednot on this mapstarted 2010, after this paper: background citation

Impact of Low Fat Milk Intake on Cardiovascular Risk Indicators in Children 6-13 Years of Age

TypeinterventionalSponsorInstituto Nacional de Salud Publica, MexicoRan2010 to 2011Enrolled650ConditionsCardiovascular DiseasesArmsModification of the content of fat in milk, Modification of the content of cows milk, Modification of the fat content of cows´ milk
NCT01988454 completednot on this mapstarted 2011, after this paper: background citation

Characterization of Dyslipidemia in Adolescent Obesity

TypeobservationalSponsorHealth Diagnostic Laboratory, Inc.Ran2011 to 2014Enrolled50ConditionsObesity
NCT02346006 nacompletednot on this mapstarted 2015, after this paper: background citation

CHAMPS Eye Study - Myopia and Retinal Vascular Geometry in Relation to Physical Activity.

TypeinterventionalSponsorOdense University HospitalRan2015 to 2017Enrolled307ConditionsChild, Motor Activity, MyopiaArmsMore physical activity.
NCT02993458 naterminatednot on this mapstarted 2016, after this paper: background citation

DASH-Sodium Trial in Adolescents

TypeinterventionalSponsorPurdue UniversityRan2016 to 2017Enrolled79ConditionsBlood High PressureArmsDASH diet, Low Na diet, High Na diet, Usual Diet
3 · Its place in the literature

Who cites it

1,098 citing papers in PubMed, 5 syntheses or guidelines pooled it, 3,960 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Early-life adversity before age 5 is associated with reduced cardiometabolic health characterized by increased arterial stiffness and inflammation in adolescence.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

1,038 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

G S BerensonTulane Center for Cardiovascular Health, Tulane School of Public Health and Tropical Medicine, New Orleans, LA 70112-2824, USA.
S R Srinivasan
W Bao
W P Newman
R E Tracy
W A Wattigney
Tulane University · USUniversity Medical Center New Orleans · US

Funding

EARLY NATURAL HISTORY OF ARTERIOSCLEROSISU01HL038844 · TULANE UNIVERSITY OF LOUISIANA · 1997 to 2001
$2.3M
CHILDHOOD PREDICTOR OF ADULT CORONARY ARTERY DISEASER01HD032194 · TULANE UNIVERSITY OF LOUISIANA · 1994 to 1998
EPIDEMIOLOGIC RESEARCH ON ARTERIOSCLEROSISR01HL038844 · TULANE UNIVERSITY OF LOUISIANA · 1987 to 1996
NHLBI NIH HHS HL-38844NICHD NIH HHS HD-32194
6 · The paper itself

Abstract

backgroundIn adults, cardiovascular risk factors reinforce each other in their effect on cardiovascular events. However, information is scant on the relation of multiple risk factors to the extent of asymptomatic atherosclerosis in young people.

methodsWe performed autopsies on 204 young persons 2 to 39 years of age, who had died from various causes, principally trauma. Data on antemortem risk factors were available for 93 of these persons, who were the focus of this study. We correlated risk factors with the extent of atherosclerosis in the aorta and coronary arteries.

resultsThe extent of fatty streaks and fibrous plaques in the aorta and coronary arteries increased with age. The association between fatty streaks and fibrous plaques was much stronger in the coronary arteries (r=0.60, P<0.001) than in the aorta (r=0.23, P=0.03). Among the cardiovascular risk factors, body-mass index, systolic and diastolic blood pressure, and serum concentrations of total cholesterol, triglycerides, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol, as a group, were strongly associated with the extent of lesions in the aorta and coronary arteries (canonical correlation [a measure of the association between groups of variables]: r=0.70; P<0.001). In addition, cigarette smoking increased the percentage of the intimal surface involved with fibrous plaques in the aorta (1.22 percent in smokers vs. 0.12 percent in nonsmokers, P=0.02) and fatty streaks in the coronary vessels (8.27 percent vs. 2.89 percent, P=0.04). The effect of multiple risk factors on the extent of atherosclerosis was quite evident. Subjects with 0, 1, 2, and 3 or 4 risk factors had, respectively, 19.1 percent, 30.3 percent, 37.9 percent, and 35.0 percent of the intimal surface covered with fatty streaks in the aorta (P for trend=0.01). The comparable figures for the coronary arteries were 1.3 percent, 2.5 percent, 7.9 percent, and 11.0 percent, respectively, for fatty streaks (P for trend=0.01) and 0.6 percent, 0.7 percent, 2.4 percent, and 7.2 percent for collagenous fibrous plaques (P for trend=0.003).

conclusionsThese findings indicate that as the number of cardiovascular risk factors increases, so does the severity of asymptomatic coronary and aortic atherosclerosis in young people.

Indexed as

AdolescentAdultAortaAortic DiseasesArteriosclerosisBlood PressureBody Mass IndexCardiovascular DiseasesChildChild, PreschoolCoronary Artery DiseaseCoronary VesselsFemaleHumansLipidsLouisianaLipids

Identifiers

PMID9614255
OpenAlexW2315613231

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

and 1 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.